DNAGinkgo Bioworks Holdings, Inc.
$9.99-22% 1Y
$9.99
$5.4852 weeks$14.99
Is the price fair?
What DNA's price assumes
Ginkgo Bioworks Holdings, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 3.09× revenue.
3.09
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 0.91
Price / book · as of 2025-Q4
Details›
- Price / bookas of 2025-Q4
- 0.91
- EV / EBIToperating margin −260%: the multiple describes the denominator
- not meaningful
- Market capitalisation67.3 million shares, counted Jul 31, 2026
- $673M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.